Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

ImmunityBio (IBRX) Long-Term Debt Repayments (2016 - 2018)

Historic Long-Term Debt Repayments for ImmunityBio (IBRX) over the last 5 years, with Q4 2018 value amounting to $142000.0.

  • ImmunityBio's Long-Term Debt Repayments rose 12187.5% to $142000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $477000.0, marking a year-over-year decrease of 9760.69%. This contributed to the annual value of $477000.0 for FY2018, which is 9760.69% down from last year.
  • Latest data reveals that ImmunityBio reported Long-Term Debt Repayments of $142000.0 as of Q4 2018, which was up 12187.5% from $137000.0 recorded in Q3 2018.
  • ImmunityBio's Long-Term Debt Repayments' 5-year high stood at $14.9 million during Q3 2017, with a 5-year trough of $1000.0 in Q4 2014.
  • For the 5-year period, ImmunityBio's Long-Term Debt Repayments averaged around $1.7 million, with its median value being $97500.0 (2015).
  • Per our database at Business Quant, ImmunityBio's Long-Term Debt Repayments skyrocketed by 14938000.0% in 2017 and then tumbled by 9908.35% in 2018.
  • Quarter analysis of 5 years shows ImmunityBio's Long-Term Debt Repayments stood at $1000.0 in 2014, then skyrocketed by 12900.0% to $130000.0 in 2015, then tumbled by 83.08% to $22000.0 in 2016, then soared by 190.91% to $64000.0 in 2017, then surged by 121.88% to $142000.0 in 2018.
  • Its last three reported values are $142000.0 in Q4 2018, $137000.0 for Q3 2018, and $133000.0 during Q2 2018.